1. American Lung Association. (2010). Trends in pneumonia and influenza morbidity and mortality: American lung association research and program services epidemiology and statistics unit.
2. Bonten, M. J., Huijts, S. M., Bolkenbaas, M., Webber, C., Patterson, S., Gault, S., & Grobbee, D. E. (2015). Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults. New England Journal of Medicine, 372(12), 1114–1125. doi: 10.1056/NEJMoa1408544 .
3. Centers for Disease Control and Prevention. (2002). Influenza and pneumococcal vaccination levels among persons aged ≥65 years—United States, 2001. MMWR. Morbidity and Mortality Weekly Report, 51(45), 1019–1024.
4. Centers for Disease Control and Prevention. (2010). Interim results: State-specific seasonal influenza vaccination coverage—United States, August 2009-January 2010. MMWR. Morbidity and Mortality Weekly Report, 59(16), 477–484.
5. Centers for Disease Control and Prevention. (2011). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine from the Advisory Committee on Immunization Practices, 2010. MMWR. Morbidity and Mortality Weekly Report, 60(1), 13–15.